Aijun Liu

471 total citations
23 papers, 379 citations indexed

About

Aijun Liu is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Complementary and alternative medicine. According to data from OpenAlex, Aijun Liu has authored 23 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 8 papers in Molecular Biology and 4 papers in Complementary and alternative medicine. Recurrent topics in Aijun Liu's work include Blood Pressure and Hypertension Studies (4 papers), Heart Rate Variability and Autonomic Control (4 papers) and Neurological Disease Mechanisms and Treatments (3 papers). Aijun Liu is often cited by papers focused on Blood Pressure and Hypertension Studies (4 papers), Heart Rate Variability and Autonomic Control (4 papers) and Neurological Disease Mechanisms and Treatments (3 papers). Aijun Liu collaborates with scholars based in China, Australia and United States. Aijun Liu's co-authors include Xiu‐Juan Ma, Jianguo Liu, Ding‐Feng Su, Ruifang Yang, Lin Li, Ding‐Feng Su, Jianguo Liu, Fu‐Ming Shen, Hong Chen and Yinglong Liu and has published in prestigious journals such as Stroke, Journal of Ethnopharmacology and Frontiers in Pharmacology.

In The Last Decade

Aijun Liu

23 papers receiving 374 citations

Peers

Aijun Liu
Xiaojuan Ma China
Zhuyuan Fang China
Changgeng Fu China
Xinyue Jing China
Duen S. Chou Taiwan
Tao-Hua Lan China
Yang Jie-ren China
Sixi Zhang China
Guangtian Yang China
Hanlai Zhang China
Xiaojuan Ma China
Aijun Liu
Citations per year, relative to Aijun Liu Aijun Liu (= 1×) peers Xiaojuan Ma

Countries citing papers authored by Aijun Liu

Since Specialization
Citations

This map shows the geographic impact of Aijun Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aijun Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aijun Liu more than expected).

Fields of papers citing papers by Aijun Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aijun Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aijun Liu. The network helps show where Aijun Liu may publish in the future.

Co-authorship network of co-authors of Aijun Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Aijun Liu. A scholar is included among the top collaborators of Aijun Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aijun Liu. Aijun Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xingyuan, et al.. (2025). Inhibition of mitochondrial oxidative stress and apoptosis in the protection of Ginkgo biloba extract 50 against cognitive impairment. Journal of Ethnopharmacology. 351. 120059–120059. 2 indexed citations
2.
Wang, Panpan, Lu Liu, Aijun Liu, et al.. (2021). Author Correction: Structure of severe fever with thrombocytopenia syndrome virus L protein elucidates the mechanisms of viral transcription initiation. Nature Microbiology. 6(5). 697–698. 3 indexed citations
3.
Zhang, Yonglin, et al.. (2021). Angiotensin-(3–7) alleviates isoprenaline-induced cardiac remodeling via attenuating cAMP-PKA and PI3K/Akt signaling pathways. Amino Acids. 53(10). 1533–1543. 7 indexed citations
4.
Cheng, Ming‐He, et al.. (2021). Allisartan isoproxil reduces mortality of stroke-prone rats and protects against cerebrovascular, cardiac, and aortic damage. Acta Pharmacologica Sinica. 42(6). 871–884. 7 indexed citations
5.
Ye, Fang, Tongtong Wang, Aijun Liu, et al.. (2021). Clinical Significance of TP53 Abnormalities in Newly Diagnosed Multiple Myeloma. Turkish Journal of Hematology. 38(4). 246–253. 1 indexed citations
6.
Li, Mengting, Yan‐Qiong Cheng, Lei Zhang, et al.. (2021). The Synergistic Effect of Ginkgo biloba Extract 50 and Aspirin Against Platelet Aggregation. Drug Design Development and Therapy. Volume 15. 3543–3560. 31 indexed citations
7.
Hu, Jingjing, Xiangyu Wang, Eng Guan Chua, et al.. (2020). Prevalence and risk factors of Helicobacter pylori infection among children in Kuichong Subdistrict of Shenzhen City, China. PeerJ. 8. e8878–e8878. 9 indexed citations
8.
Cheng, Tao-Fang, Jing Zhao, Hua‐Wu Zeng, et al.. (2020). Compound Dan Zhi tablet attenuates experimental ischemic stroke via inhibiting platelet activation and thrombus formation. Phytomedicine. 79. 153330–153330. 18 indexed citations
9.
Tian, Sai, Yu Gu, Jian Yang, et al.. (2019). Systems Biology Analysis of the Effect and Mechanism of Qi-Jing-Sheng-Bai Granule on Leucopenia in Mice. Frontiers in Pharmacology. 10. 408–408. 20 indexed citations
10.
11.
Lu, Lijuan, et al.. (2014). [Expression and clinicopathologic significance of CD44v6/CD24 in ovarian serous carcinomas].. PubMed. 43(1). 20–4. 3 indexed citations
12.
Zhu, Yaobin, Yanbo Zhang, D. H. Liu, et al.. (2013). Atrial natriuretic peptide attenuates inflammatory responses on oleic acid-induced acute lung injury model in rats. Chinese Medical Journal. 126(4). 747–750. 19 indexed citations
13.
Xu, Yong, et al.. (2013). Expression of Ku86 and Presence of Ku86 Antibody as Biomarkers of Hepatitis B Virus Related Hepatocellular Carcinoma. Digestive Diseases and Sciences. 59(3). 614–622. 8 indexed citations
14.
Yu, Jian‐Guang, Enhui Zhang, Aijun Liu, et al.. (2013). Ketanserin improves cardiac performance after myocardial infarction in spontaneously hypertensive rats partially through restoration of baroreflex function. Acta Pharmacologica Sinica. 34(12). 1508–1514. 10 indexed citations
15.
Li, Gang�, et al.. (2012). Angiotensin-converting enzyme 2 activation protects against pulmonary arterial hypertension through improving early endothelial function and mediating cytokines levels.. PubMed. 125(8). 1381–8. 23 indexed citations
16.
Liu, Wei, Wei Wang, Shuwei Song, et al.. (2011). Synergism of Telmisartan and Amlodipine on Blood Pressure Reduction and Cardiorenal Protection in Hypertensive Rats. Journal of Cardiovascular Pharmacology. 57(3). 308–316. 7 indexed citations
17.
Ma, Xiu‐Juan, et al.. (2009). Effects of allisartan, a new AT1 receptor blocker, on blood pressure and end-organ damage in hypertensive animals. Acta Pharmacologica Sinica. 30(3). 307–313. 20 indexed citations
18.
Yang, Ruifang, Aijun Liu, Xiu‐Juan Ma, et al.. (2008). Sodium Tanshinone IIA Sulfonate Protects Cardiomyocytes Against Oxidative Stress-mediated Apoptosis Through Inhibiting JNK Activation. Journal of Cardiovascular Pharmacology. 51(4). 396–401. 109 indexed citations
19.
20.
Shen, Fu‐Ming, et al.. (2007). The Survival Time Post-Cecal Ligation and Puncture in Sinoaortic Denervated Rats. Journal of Cardiovascular Pharmacology. 50(2). 162–167. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaojuan Ma Breakdown of academic impact, for papers by Zhuyuan Fang Breakdown of academic impact, for papers by Changgeng Fu Breakdown of academic impact, for papers by Xinyue Jing Breakdown of academic impact, for papers by Duen S. Chou Breakdown of academic impact, for papers by Tao-Hua Lan Breakdown of academic impact, for papers by Yang Jie-ren Breakdown of academic impact, for papers by Sixi Zhang Breakdown of academic impact, for papers by Guangtian Yang Breakdown of academic impact, for papers by Hanlai Zhang
Rankless by CCL
2026